PON1 polymorphisms and/or enzyme measurements have been associated with various diseases of the nervous system, including Alzheimer’s disease (Erlich et al. 2006; Leduc and Poirier 2008; Paragh et al. 2002), brain tumors (Kafadar et al. 2006), vascular dementia (Paragh et al. 2002), amyotrophic lateral sclerosis (Saeed et al. 2006; Slowik et al. 2006), ischemic stroke (Voetsch et al. 2002, 2004), and Parkinson disease (Zintzaras and Hadjigeorgiou 2004). The gene discussed is PON1; the disease is Parkinson disease.